Victus granted 510(k) clearance for lens fragmentation procedure

Valeant announced Bausch + Lomb has received 510(k) clearance from the U.S. Food and Drug Administration for the Victus Femtosecond Laser Platform for femtosecond laser-assisted lens fragmentation during cataract and refractive surgery.The Victus platform provides a variety of lens fragmentation patterns depending on the cataract grade and user preference, according to a company press release.